| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
133,000,000 |
| Market
Cap: |
798.00(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.1 - $9.51 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cytek Biosciences is a cell analysis solutions company developing cell analysis tools by using technical approaches. Co. has developed and manufactured its full spectrum flow cytometry platform. Co.'s main instruments, the Aurora and Northern Lights systems, are the full spectrum flow cytometers able to deliver high-resolution, high-content and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Co.'s Full Spectrum Profiling platform includes instruments, accessories, reagents, software, and services to provide an integrated suite of solutions for its customers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
61,900 |
84,900 |
322,900 |
857,389 |
| Total Sell Value |
$400,304 |
$617,404 |
$2,272,864 |
$8,534,382 |
| Total People Sold |
1 |
2 |
3 |
4 |
| Total Sell Transactions |
4 |
6 |
23 |
61 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Yan Ming |
Chief Technology Officer |
• • – |
2022-05-19 |
4 |
AS |
$9.92 |
$198,400 |
D/D |
(20,000) |
8,104,415 |
|
45% |
|
| Jeanmonod Patrik |
Chief Financial Officer |
• – – |
2022-05-18 |
4 |
D |
$9.65 |
$8,782 |
D/D |
(910) |
97,423 |
|
- |
|
| Jeanmonod Patrik |
Chief Financial Officer |
• – – |
2022-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,336 |
98,333 |
|
- |
|
| Barnett Valerie |
General Counsel |
• – – |
2022-05-18 |
4 |
D |
$9.65 |
$10,104 |
D/D |
(1,047) |
14,041 |
|
- |
|
| Barnett Valerie |
General Counsel |
• – – |
2022-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,688 |
15,088 |
|
- |
|
| Jiang Wenbin |
President and CEO |
• • – |
2022-05-18 |
4 |
D |
$9.65 |
$33,872 |
D/D |
(3,510) |
7,901,541 |
|
- |
|
| Jiang Wenbin |
President and CEO |
• • – |
2022-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,011 |
7,905,051 |
|
- |
|
| Poirson Allen |
SVP Marketing and Corp. Dev. |
• – – |
2022-05-18 |
4 |
D |
$9.65 |
$3,966 |
D/D |
(411) |
41,025 |
|
- |
|
| Poirson Allen |
SVP Marketing and Corp. Dev. |
• – – |
2022-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,053 |
41,436 |
|
- |
|
| Yan Ming |
Chief Technology Officer |
• • – |
2022-05-18 |
4 |
D |
$9.65 |
$9,940 |
D/D |
(1,030) |
8,124,415 |
|
- |
|
| Yan Ming |
Chief Technology Officer |
• • – |
2022-05-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,642 |
8,125,445 |
|
- |
|
| Jiang Wenbin |
President and CEO |
• • – |
2022-05-09 |
4 |
AS |
$8.01 |
$160,200 |
D/D |
(20,000) |
7,896,040 |
|
62% |
|
| Yan Ming |
Chief Technology Officer |
• • – |
2022-04-19 |
4 |
AS |
$10.34 |
$206,800 |
D/D |
(20,000) |
8,122,803 |
|
12% |
|
| Jiang Wenbin |
President and CEO |
• • – |
2022-04-07 |
4 |
AS |
$10.54 |
$210,800 |
D/D |
(20,000) |
7,916,040 |
|
32% |
|
| Yan Ming |
Chief Technology Officer |
• • – |
2022-03-21 |
4 |
AS |
$11.64 |
$232,800 |
D/D |
(20,000) |
8,142,803 |
|
13% |
|
| Shah Rajeev M. |
Director |
– • • |
2022-03-15 |
4 |
AB |
$12.27 |
$2,964,999 |
I/I |
241,727 |
13,381,054 |
|
-2% |
|
| Shah Rajeev M. |
Director |
– • • |
2022-03-14 |
4 |
AB |
$12.35 |
$4,223,926 |
I/I |
342,143 |
13,139,327 |
|
-1% |
|
| Shah Rajeev M. |
Director |
– • – |
2022-03-11 |
4 |
AB |
$12.77 |
$4,309,334 |
I/I |
337,492 |
12,797,184 |
|
-0% |
|
| Shah Rajeev M. |
Director |
– • – |
2022-03-10 |
4 |
AB |
$12.95 |
$3,327,584 |
I/I |
256,992 |
12,459,692 |
|
-7% |
|
| Shah Rajeev M. |
Director |
– • – |
2022-03-09 |
4 |
AB |
$12.99 |
$521,753 |
I/I |
40,154 |
12,202,700 |
|
-10% |
|
| Shah Rajeev M. |
Director |
– • – |
2022-03-08 |
4 |
AB |
$12.86 |
$3,160,059 |
I/I |
245,701 |
12,162,546 |
|
-12% |
|
| Jiang Wenbin |
President and CEO |
• • – |
2022-03-07 |
4 |
AS |
$12.58 |
$253,052 |
D/D |
(20,000) |
7,936,040 |
|
-2% |
|
| Yan Ming |
Chief Technology Officer |
• • – |
2022-03-07 |
4 |
OE |
$0.25 |
$25,325 |
D/D |
73,011 |
8,162,803 |
|
- |
|
| Shah Rajeev M. |
Director |
– • – |
2022-03-07 |
4 |
AB |
$12.61 |
$4,260,965 |
I/I |
337,901 |
11,916,845 |
|
-2% |
|
| Jiang Wenbin |
President and CEO |
• • – |
2022-03-04 |
4 |
OE |
$0.25 |
$16,666 |
D/D |
66,665 |
7,956,040 |
|
- |
|
226 Records found
|
|
Page 8 of 10 |
|
|
0.03 (0.5%) 
